About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3707398
Allelic
Composition
Faslpr/Faslpr
Genetic
Background
B6.MRL-Faslpr/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (83 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• after bile duct ligation (BDL), Peyer's patch B cells do not display evidence of apoptosis
• plasmablast numbers in spleen are increased relative to wild-type
• higher numbers of T2 B cells in spleen relative to wild-type
• higher in spleen relative to wild-type
• higher in spleen relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
• T1:follicular B cell ratio is higher than wild-type or Bcl2l11-deficient mice
• total number of CD19+ splenocytes is higher than wild-type
• total number of splenocytes is increased relative to wild-type
• continuous treatment with recombinant murine IL12 results in sustained recruitment of NK cells to the liver
• mice develop less severe lymphadenopathy at later ages than the double mutant Igh-6/Fas mice
• total number of cells per lymph node is increased compared to wild-type
• total anti-IgM antibody levels are increased compared to wild-type
• anti-nuclear antibodies are increased compared to wild-type
• anti-ssDNA IgM and IgG antibodies are increased compared to wild-type
• increased compared to wild-type
• anti-ssDNA IgM and IgG antibodies are increased compared to wild-type
• by 7 days after TMEV infection, inflammation is present, decreasing slightly by 21 days, but widespread tissue damage is present, similar to controls (B6)
• tissue damage is less frequent at 45 days than in Prf-null mice
• mice infected with 500 CFU of S. aureus have drastically elevated number of S. aureus CFU compared to similarly-infected wild-type mice, but lower counts than infected Faslgld mice
• inflammation and tissue damage in the brain are slightly greater than in control, resistant mice at 45 and 180 days

hematopoietic system
• after bile duct ligation (BDL), Peyer's patch B cells do not display evidence of apoptosis
• plasmablast numbers in spleen are increased relative to wild-type
• higher numbers of T2 B cells in spleen relative to wild-type
• higher in spleen relative to wild-type
• higher in spleen relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
• T1:follicular B cell ratio is higher than wild-type or Bcl2l11-deficient mice
• total number of CD19+ splenocytes is higher than wild-type
• total number of splenocytes is increased relative to wild-type
• continuous treatment with recombinant murine IL12 results in sustained recruitment of NK cells to the liver

renal/urinary system
• higher numbers of apoptotic cells are detected in glomeruli compared to wild-type
• number of macrophages surrounding glomeruli is increased compared to wild-type which have no macrophage index
• IgG deposits mainly localized to glomerular basement membrane are increased relative to wild-type

liver/biliary system
• confluent foci of feathery hepatocyte degeneration due to bile acid cytotoxicity are significantly reduced compared to controls hours after BDL
• necroinflammatory foci after BDL are reduced in number compared to controls
• when mice are recipients of wild-type hepatitis B surface antigen (HBsAg)-specific Th1 cells after treatment with HBsAg, severe liver injury is induced to similar extent as in wild-type mice (J:120559)
• treatment with Prf1-deficient HBsAg-specific Th1 cells and HBsAg induces liver injury as severe as that induced by wild-type HBsAg-specific Th1 cells (J:120559)
• after BDL, necroinflammatory foci and lymphocytic infiltration are obviously less than in controls (J:135830)
• hepatocyte cell death is reduced compared to controls after BDL

nervous system
• by 7 days after TMEV infection, inflammation is present, decreasing slightly by 21 days, but widespread tissue damage is present, similar to controls (B6)
• tissue damage is less frequent at 45 days than in Prf-null mice
• by 7 days after TMEV infection, inflammation is present in the meninges and gray matter of spinal cord, but decreases by 21 days, although not as much as in controls (B6)

cellular
• after bile duct ligation (BDL), Peyer's patch B cells do not display evidence of apoptosis
• higher numbers of apoptotic cells are detected in glomeruli compared to wild-type
• hepatocyte cell death is reduced compared to controls after BDL


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/28/2026
MGI 6.24
The Jackson Laboratory